Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Taiho Oncology
Taiho Oncology
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Lonsurf
Tipiracil
,
Trifluridine
2015-09-22
2029-2037
Colorectal neoplasms
,
Virus diseases
,
Herpetic keratitis
,
Infectious keratoconjunctivitis
Lytgobi
Futibatinib
2022-09-30
2033-2039
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tipiracil
neoplasms
,
breast neoplasms
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
renal insufficiency
,
pancreatic ductal carcinoma
,
pancreatic neoplasms
,
adenocarcinoma
,
cholangiocarcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
bile duct neoplasms
,
carcinoma
,
squamous cell neoplasms
,
urinary bladder neoplasms
,
neuroendocrine carcinoma
,
colorectal neoplasms
,
stomach neoplasms
Trifluridine
neoplasms
,
breast neoplasms
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
renal insufficiency
,
pancreatic ductal carcinoma
,
pancreatic neoplasms
,
adenocarcinoma
,
cholangiocarcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
bile duct neoplasms
,
carcinoma
,
squamous cell neoplasms
,
urinary bladder neoplasms
,
neuroendocrine carcinoma
,
colorectal neoplasms
,
stomach neoplasms
Futibatinib
non-small-cell lung carcinoma
,
neoplasms
,
breast neoplasms
,
non-hodgkin lymphoma
,
multiple myeloma
,
transitional cell carcinoma
,
stomach neoplasms
,
gene rearrangement
,
pancreatic neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
cholangiocarcinoma
,
biliary tract neoplasms
,
neoplasm metastasis
Transplatin
renal insufficiency
,
lung neoplasms
,
pancreatic neoplasms
,
neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
stomach neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
cholangiocarcinoma
,
biliary tract neoplasms
Zanidatamab
biliary tract neoplasms
Aglatimagene besadenovec
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
neoplasms
Amrubicin
lung neoplasms
,
small cell lung carcinoma
Ademetionine
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myelomonocytic leukemia chronic
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
Doconexent
neoplasms
,
non-hodgkin lymphoma
,
multiple myeloma
,
stomach neoplasms
,
carcinoma
Sodium chloride
cholangiocarcinoma
Aspartame
breast neoplasms
Bevifimod
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
neoplasms
,
non-hodgkin lymphoma
,
multiple myeloma
,
biliary tract neoplasms
Doxribtimine
bile duct neoplasms
,
cholangiocarcinoma
Nepidermin
non-small-cell lung carcinoma
PIMITESPIB
neoplasms
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use